# Vorinostat and Palliative Radiotherapy

> **NCT00455351** · PHASE1 · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 15 (actual)

## Conditions studied

- Pelvic Cancer
- Radiotherapy

## Interventions

- **DRUG:** Vorinostat

## Key facts

- **NCT ID:** NCT00455351
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2009-03
- **Final completion:** 2009-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00455351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00455351, "Vorinostat and Palliative Radiotherapy". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00455351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*